GridAI Technologies

GRDXNASDAQUSD

THESIS ALERT

Email me when the GRDX thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$5.70
+$0.14 (+2.52%)Today 1M +14.69%

Updated Nov 11, 12:34 PM ET · Regular session · May be delayed

—
Source valuation snapshot. Not a live recalculation.
—
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
—
Diluted earnings per share from the latest filed annual.
$5.56
Prior regular-session close from the quote source.
$5.65–$5.86
Regular-session low and high so far today.
23.5K
Regular-session shares traded · Nov 11, 12:34 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$1.87–$6.93
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own GRDX if the newly acquired Grid AI/AMPX business turns AI data-center power constraints into paid, repeatable energy-orchestration revenue before cash and dilution become the dominant outcome.

GRDX price history

LATEST PRICE$5.70TODAY+$0.14 (+2.52%)
GRDX +21.28%S&P 500 -2.23%Since first plotted close
4 hours

Loading recent earnings…

INVESTMENT THESIS

What must happen next

4 MATERIAL PROPOSITIONS
  • AI data-center power scarcity gives Grid AI a commercialization wedge, but that wedge must convert the re-established consulting-led BESS pipeline into paying deployments rather than remain business-development activity.WeakeningMateriality: High

    Item 1 says Grid AI develops software and services designed to accelerate power availability and optimize energy infrastructure for AI data centers and other large energy users. If paid deployments appear, GRDX can start being valued as an energy-technology business; if they do not, the current valuation is mostly unsupported option value.

    Watch: Mango Power, Nomad Transportable Power Systems, or other BESS participants choose incumbent energy-management vendors instead of progressing to paid Grid AI deployments.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Item 1 says Grid AI develops software and services designed to accelerate power availability and optimize energy infrastructure for AI.

    Open source ↗
  • The grid platform must become a repeatable software-enabled offering with positive delivery economics, not bespoke integration work whose costs scale faster than customer adoption.WeakeningMateriality: High

    Item 1 says management is prioritizing lower-friction, near-term opportunities that can be pursued with limited incremental cost. Revenue growth would not create owner value if each deployment requires heavy customization and remains gross-loss-making.

    Watch: BESS and data-center projects require customer-specific engineering, hardware integration, and site-by-site interconnection work that prevents software-like economics.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Item 1 says management is prioritizing lower-friction, near-term opportunities that can be pursued with limited incremental cost.

    Open source ↗
  • The strategic clean-up must keep legacy biotech obligations from consuming the capital and management attention needed to commercialize Grid AI.HoldingMateriality: Medium

    MD&A says the company rescinded the ImmunogenX acquisition, transferred ImmunogenX back to former shareholders, and left ImmunogenX responsible for approximately $9.3 million of secured debt. If legacy programs reabsorb resources, the energy pivot becomes a branding change rather than an economic transformation.

    Watch: Adrulipase development requires a new clinical trial, regulatory spend, or partnership costs that compete with Grid AI commercialization funding.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    MD&A says the company rescinded the ImmunogenX acquisition, transferred ImmunogenX back to former shareholders, and left ImmunogenX responsible for approximately.

    Open source ↗
  • GRDX must secure enough runway on acceptable terms for the grid pivot to mature; otherwise financing pressure, not technology adoption, will determine per-share value.WeakeningMateriality: Medium

    Cash increased from $163,476 at FY2024 year-end to $899,784 at FY2025 year-end. Even a promising product can fail as an equity investment if survival requires heavy dilution before customer traction appears.

    Watch: The company raises capital through highly dilutive equity, warrants, or preferred securities before grid revenue scales.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Cash increased from $163,476 at FY2024 year-end to $899,784 at FY2025 year-end.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

AI data-center power scarcity gives Grid AI a commercialization wedge, but that wedge must convert the re-established consulting-led BESS pipeline into paying deployments rather than remain business-development activity. If paid deployments appear, GRDX can start being valued as an energy-technology business; if they do not, the current valuation is mostly unsupported option value.

The grid platform must become a repeatable software-enabled offering with positive delivery economics, not bespoke integration work whose costs scale faster than customer adoption. Revenue growth would not create owner value if each deployment requires heavy customization and remains gross-loss-making.

The strategic clean-up must keep legacy biotech obligations from consuming the capital and management attention needed to commercialize Grid AI. If legacy programs reabsorb resources, the energy pivot becomes a branding change rather than an economic transformation.

GRDX must secure enough runway on acceptable terms for the grid pivot to mature; otherwise financing pressure, not technology adoption, will determine per-share value. Even a promising product can fail as an equity investment if survival requires heavy dilution before customer traction appears.

All standing thesis claims
Original report summary

the newly acquired Grid AI/AMPX business turns AI data-center power constraints into paid, repeatable energy-orchestration revenue before cash and dilution become the dominant outcome.

Evidence assessed Oct 15, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

BULL CASE / BEAR CASE

Bull case and bear case for GridAI Technologies

Where the evidence on GridAI Technologies disagrees: Mixed on the latest evidence (Oct 15, 2026). Of its 4 thesis points, 1 holding and 3 weakening.

Bull case: what the evidence supports

  • The strategic clean-up must keep legacy biotech obligations from consuming the capital and management attention needed to commercialize Grid AI.

    sec.gov ↗

Bear case: what the evidence questions

  • AI data-center power scarcity gives Grid AI a commercialization wedge, but that wedge must convert the re-established consulting-led BESS pipeline into paying deployments rather than remain business-development activity.

    sec.gov ↗

  • The grid platform must become a repeatable software-enabled offering with positive delivery economics, not bespoke integration work whose costs scale faster than customer adoption.

    sec.gov ↗

  • GRDX must secure enough runway on acceptable terms for the grid pivot to mature; otherwise financing pressure, not technology adoption, will determine per-share value.

    sec.gov ↗

Thesis-Break Engine

What has broken in GridAI Technologies’s thesis

Each break OptimistFi flagged on GridAI Technologies, dated — with what has historically followed the same kind of break across the market, not a forecast for GridAI Technologies.

peers+15%-20%-2%12 mo agonow+6 mo
Daily price, then where similar breaks led across the market: the typical -2% path vs comparable companies over six months, inside the middle-half range (+15% to -20%). A base rate, not a forecast.
  • CEO / officer changecondition set before this filing

    Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. MIXED
    Entered a material definitive agreement.

    GridAI Technologies filed an SEC 8-K on 2026-10-07: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  2. MIXED
    Entered a material definitive agreement.

    GridAI Technologies filed an SEC 8-K on 2026-09-11: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  3. MIXED
    Entered a material definitive agreement.

    GridAI Technologies filed an SEC 8-K on 2026-07-23: Entered a material definitive agreement. It is a dated development that tests the current thesis.

RISKS / FALSIFIERS

What could break the thesis

  • Mango Power, Nomad Transportable Power Systems, or other BESS participants choose incumbent energy-management vendors instead of progressing to paid Grid AI deployments.
  • BESS and data-center projects require customer-specific engineering, hardware integration, and site-by-site interconnection work that prevents software-like economics.
  • Adrulipase development requires a new clinical trial, regulatory spend, or partnership costs that compete with Grid AI commercialization funding.
  • The company raises capital through highly dilutive equity, warrants, or preferred securities before grid revenue scales.

GRDX news

Loading headlines…

FINANCIAL STATEMENTS

GRDX income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

GRDX: quick answers

What is GRDX's short interest?
As of October 30, 2026, 30,489 GRDX shares were sold short, down 69.3% from the count before. At the stock's average daily volume that is 1.0 day to cover. FINRA publishes the count twice a month. GRDX short interest history
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.